Fifteen prescription medications will be the focus of federal price negotiations that could lower prices for Medicare patients.

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

List includes medications for diabetes, cancer, arthritis, and more ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Medicare picks Botox and Trulicity for latest round of negotiations The Centers for ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

Before you schedule an injection, read this.